2018
DOI: 10.2147/jpr.s185582
|View full text |Cite
|
Sign up to set email alerts
|

Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management

Abstract: This narrative review aims to highlight the current paradigm on pain management in sickle cell vaso-occlusive crisis. It specifically examines the pathophysiologic mechanisms of sickle cell pain as well as the pharmacologic and nonpharmacologic methods of pain management. Recurrent painful episodes constitute the major morbidity in sickle cell disease (SCD). While adolescents and young adults experience mostly acute episodic nociceptive pain, it is now recognized that a significant number of adult patients dev… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
46
1
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(51 citation statements)
references
References 75 publications
2
46
1
2
Order By: Relevance
“…However, those that do not have a pulmonary infiltrate are considered to have uncomplicated VOC. Although labeled uncomplicated VOC, the treatment and pain management is quite complex and requires multiple pharmacologic, nonpharmacologic, and preventative therapeutic interventions [13]. In the simplest cases, the patient is treated, recovers, and is discharged from the hospital.…”
Section: Spectral Analysis Of Lung Acousticsmentioning
confidence: 99%
“…However, those that do not have a pulmonary infiltrate are considered to have uncomplicated VOC. Although labeled uncomplicated VOC, the treatment and pain management is quite complex and requires multiple pharmacologic, nonpharmacologic, and preventative therapeutic interventions [13]. In the simplest cases, the patient is treated, recovers, and is discharged from the hospital.…”
Section: Spectral Analysis Of Lung Acousticsmentioning
confidence: 99%
“…Contributing to microvascular occlusion is a greater capacity for neutrophil extracellular trap (NET) formation characterized by decondensed chromatin enriched in citrullinated histones and bound to granular enzymes ( 9 ). The pathophysiology and requirement for pain management directly associated with VOC in patients has been extensively reviewed ( 2 , 4 , 6 , 10 , 11 ). As such, the focus of this review is to highlight the role of neutrophils in the initiation and propagation of VOC, as well as targeted pharmacological interventions against adhesion molecules critical for neutrophil recruitment and heterotypic adhesion with other blood cells during flow within vessels.…”
Section: Introductionmentioning
confidence: 99%
“…immunization injections) cause the release of mediators from the injured tissue which, in turn, activate and/ or sensitize the nociceptors to the noxious stimuli (Omoigui, 2007). Activation of nociceptors generates an action potential (de-polarisation and re-polarisation) at the cell membranes of injured tissue which, in turn, stimulates the nociceptive nerve terminals (Orhurhu et al, 2019;Uwaezuoke et al, 2018). Activation of the nerve terminals promotes the release of several neurotransmitters (exhibitory chemicals) that permit transduction and transmission of the pain stimuli through the spinal cord to the brain pathway where pain is perceived and responses are elicited (Caterina & Julius, 2001;Orhurhu et al, 2019;Szallasi & Blumberg, 1999;Uwaezuoke et al, 2018).…”
Section: Introductionmentioning
confidence: 99%